Get access

Diagnostics, surveillance and management of sexually transmitted infections in Europe have to be improved: lessons from the European Conference of National Strategies for Chlamydia Trachomatis and Human Papillomavirus (NSCP conference) in Latvia, 2011


  • D. Ozolins,

    Corresponding author
    1. University of Latvia, Riga, Latvia
    Search for more papers by this author
  • M.M. D’Elios,

    1. University of Florence, Florence, Italy
    Search for more papers by this author
  • C.M. Lowndes,

    1. Health Protection Agency (HPA), London, UK
    Search for more papers by this author
  • M. Unemo,

    1. Örebro University Hospital, Örebro, Sweden
    Search for more papers by this author
  • on behalf of the members of the NSCP Conference Scientific Committee

    Search for more papers by this author
    • Christopher Barbara (Malta), Bertille de Barbeyrac (France), Maria Jose Borrego (Portugal), Tania Crucitti (Belgium), Alexandros Daponte (Greece), Marius Domeika (Sweden), Viorica Gheorghiu (Romania), Karin Haar (Germany), Björn Herrmann (Sweden), Steen Hoffmann (Denmark), Kai Joers (Estonia), Margaretha Jurstrand (Sweden), Hilde Klovstad (Norway), Juta Kroica (Latvia), Vesta Kucinskiene (Lithuania), Servaas A. Morre (The Netherlands), Sander Ouburg (The Netherlands), Michael Pfleiderer (Germany), Mirja Puolakkainen (Finland), Dace Rezeberga (Latvia), Magdalena Rosinska (Poland), Peter Sasieni (UK), Emma Savage (UK), Par Sparen (Sweden), Inga Velicko (Sweden), and Aija Zilevica (Latvia).

  • Funding sources
    The conference took place as a result of the project ‘European Conference of National Strategies for Chlamydia trachomatiis and Human Papillomavirus-NSCP’, which received funding from the European Union within the framework of the Public Health Programme.

  • Conflicts of interest
    None declared.

D. Ozolins.


Background  There is an urgent need for the recognition of sexually transmitted infections (STIs) as a serious public health problem in Europe. The lack of standardization in testing, along with poor reporting and surveillance mechanisms, have resulted in low reported rates of STIs in many European Union (EU) countries, reinforcing the erroneous assumption that STIs are not a major problem. Testing and diagnosis of STIs must therefore be improved and enhanced.

Recommendations  Reporting of Chlamydia trachomatis infection, gonorrhoea and syphilis should be mandatory, and an integrated surveillance system for C. trachomatis implemented in all European countries. Implementation of the European Centre for Disease Prevention and Control (ECDC) surveillance mechanisms for STIs in all EU countries is highly recommended. A necessary component for successful introduction of the HPV vaccine, as with any vaccination programme is a well-planned and organized information campaign.